Leading the Biotech team at Panakes Partners since 2021, Rob has global experience in biotech and pharma gained in both institutional and corporate venture firms, encompassing de novo start-up through to growth investments, with a track record of value creation in all of these settings as demonstrated by multiple acquisitions and NASDAQ listings of the companies he has invested in. Previously, Rob was Senior Partner at Takeda Ventures, and was also the Head of Genesis Labs, Takeda’s internal concept incubator. Prior to joining Takeda, Rob was Director of Healthcare Investments at Touchstone Innovations (formerly Imperial Innovations) and before this, Rob was a Principal in the life science team at Sofinnova Partners, a leading European venture capital firm.